TriaGen Wealth Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
TriaGen Wealth Management's MDT Position: Q1 2026 in Review
TriaGen Wealth Management sold out of Medtronic (MDT) in Q1 2026, closing a stake of 25,186 shares — an estimated $2.42M sold.
TriaGen Wealth Management first reported a position in MDT in Q4 2020 and held it in 5 quarters. The position peaked at $2.42M in Q4 2025. 2,248 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- TriaGen Wealth Management reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
- TriaGen Wealth Management sold 25,186 Medtronic shares in Q1 2026, an estimated $2.42M.
- TriaGen Wealth Management first reported a position in Medtronic in Q4 2020 and held it in 5 quarters.
- TriaGen Wealth Management's Medtronic position peaked at $2.42M in Q4 2025.
- 2,248 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on TriaGen Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.